RecruitingNot ApplicableNCT05838638

Serious Gaming for Chemotherapy-induced Nausea and Vomiting

Serious Gaming for Chemotherapy-induced Nausea and Vomiting in Older Adults With Cancer: A Randomized Clinical Trial


Sponsor

University of Central Florida

Enrollment

610 participants

Start Date

Jun 9, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

The purpose of this study is to examine the effectiveness of a technology-based intervention for managing nausea and vomiting in older adults with cancer. Participants will be randomized to either an intervention or control group. Outcomes such as symptom severity, quality of life, and resource use will be examined.


Eligibility

Min Age: 60 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a behavioral approach called eSSET-CINV for people with chemotherapy induced nausea and vomiting and neoplasms. The study is currently recruiting participants at 2 locations. People eligible for this study include aged 60 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALeSSET-CINV

Participants in the intervention group will be asked to play the serious game on an iPad at their first chemotherapy treatment visit. The control group will be able to play at time 6.


Locations(2)

Miller School of Medicine Sylvester Comp. Cancer Center

Miami, Florida, United States

Orlando Health

Orlando, Florida, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05838638


Related Trials